Suchergebnisse - "1865-8652"

PubPharm (541)

81

Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer : Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison

enthalten in: Advances in therapy | 2022

von Chowdhury, S. | Oudard, S. | Uemura, H. | +6

82

Pharmacokinetics, Pharmacodynamics, and Safety of Dulaglutide After Single or Multiple Doses in Chinese Healthy Subjects and Patients with T2DM : A Randomized, Placebo-Controlled, Phase I Study

enthalten in: Advances in therapy | 2022

von Xu, J. | Zhang, Y. | Li, Y. | +7

83

Influence of Fasting Plasma Glucose Targets on Glycemic Variability in Chinese Participants With Type 2 Diabetes : A Post Hoc Analysis of the FPG GOAL Trial (BEYOND III)

enthalten in: Advances in therapy | 2022

von Li, L. | Yang, T. | Xue, Y. | +6

CommentIn: Adv Ther. 2022 Jan;39(1):1-4. - PMID 34757599

84

Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension : Results from GRIPHON and its Open-Label Extension

enthalten in: Advances in therapy | 2022

von Galiè, N. | Gaine, S. | Channick, R. | +10

85

The Contribution of Galenics to Patients' Sensory Perception of Nasal Sprays After Nasal Surgery : Data from a Prospective Randomised, Controlled, Double-Blind, Crossover, Multicentre Study

enthalten in: Advances in therapy | 2021

von Bergmann, C. | Lander, J. | Radtke, L. | +3

86

Sedation Effects Produced by a Ciprofol Initial Infusion or Bolus Dose Followed by Continuous Maintenance Infusion in Healthy Subjects : A Phase 1 Trial

enthalten in: Advances in therapy | 2021

von Hu, C. | Ou, X. | Teng, Y. | +5

87

Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures : Results from the Open-Label Period of the CONQUER Trial

enthalten in: Advances in therapy | 2021

von Reuter, U. | Lucas, C. | Dolezil, D. | +6

88

Mapping Migraine-Specific Quality of Life to Health State Utilities in Patients Receiving Rimegepant

enthalten in: Advances in therapy | 2021

von Johnston, K. | L'Italien, G. | Popoff, E. | +6

89

Cost-Effectiveness Analysis of Anlotinib as Third- or Further-Line Treatment for Relapsed Small Cell Lung Cancer (SCLC) in China

enthalten in: Advances in therapy | 2021

von Gong, J. | Wan, Q. | Shang, J. | +4

90

Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis : A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES)

enthalten in: Advances in therapy | 2021

von Csiky, B. | Schömig, M. | Esposito, C. | +4